Ontology highlight
ABSTRACT:
SUBMITTER: Pattanaik S
PROVIDER: S-EPMC6517182 | biostudies-literature | 2018 Nov
REPOSITORIES: biostudies-literature
Pattanaik Smita S Mavuduru Ravimohan S RS Panda Arabind A Mathew Joseph L JL Agarwal Mayank M MM Hwang Eu Chang EC Lyon Jennifer A JA Singh Shrawan K SK Mandal Arup K AK
The Cochrane database of systematic reviews 20181116
<h4>Background</h4>Benign prostatic hyperplasia (BPH) refers to non-malignant enlargement of the prostate gland that may cause bothersome lower urinary tract symptoms (LUTS). Alpha-blockers (ABs) and 5-alpha reductase inhibitors (5-ARIs) are the mainstay of medical treatment. Recently, phosphodiesterase inhibitors (PDEIs) that so far have been used mainly to treat erectile dysfunction were introduced to treat male LUTS.<h4>Objectives</h4>To assess the effects of PDEIs compared to placebo and oth ...[more]